With recent advances in photonics and optical molecular probes, optical imaging plays an increasingly important role in preclinical and clinical imaging. A fundamental constraint of optical imaging is light diffusion, which limits the spatial resolution in deep-tissue imaging. In the past decade, photoacoustic (PA) tomography (PAT) has emerged as a promising modality that overcomes this challenge. PAT capitalizes on the photoacoustic effect, which converts absorbed optical energy into acoustic energy. Because acoustic waves scatter much less than optical waves in tissue, PAT can generate high-resolution images in both the optically ballistic and diffusive regimes. With signals originating from optical absorption, PAT readily takes advantage of rich endogenous and exogenous optical contrasts.
FUJIFILM VisualSonics And iThera Medical GmbH – Notable Market Players in Photoacoustic Tomography Market
The photoacoustic tomography market is majorly comprised of top players involving FUJIFILM VisualSonics Inc.; TomoWave Laboratories, Inc.; Advantest Corporation; kibero; Seno Medical Instruments; iThera Medical GmbH; Aspectus GmbH; OPOTEK LLC.; CYBERDYNE Inc.; and InnoLas Laser GmbH.
The companies listed above are implementing various strategies such as product launches, acquisitions, mergers, and partnerships, which have resulted in the company’s growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Below is the list of the growth strategies done by the players operating in the photoacoustic tomography market:
| Year | News |
| June-2020 | FUJIFILM VisualSonics Inc a subsidiary of FUJIFILM SonoSite, Inc has launched the Vevo F2, the world’s first ultra high to low frequency ultrasound imaging system with a frequency range stretching from 71-1 MHz. |
| Oct-2021 | iThera Medical announced the launch of its new inVision TRIO preclinical optoacoustic imaging system. The inVision TRIO is the world’s first imaging system that include transmission ultrasonic computed tomography (TUCT), broadening the range of biomedical applications that iThera Medical’s optoacoustic imaging systems. |
| Feb-2022 | FUJIFILM VisualSonics, Inc. and PIUR IMAGING announced a partnership for bringing UHF, three-dimensional (3D) ultrasound imaging technology to clinicians and researchers. |
| Oct-2021 | iThera Medical announced the successful funding of Horizon Europe technology innovation project FRONTIER. With this project, iThera Medical will translate its proprietary optoacoustic imaging technology from a research environment to application in routine clinical imaging, thus offering clinicians globally with a powerful new diagnostic tool. |
